European Lung Cancer Congress – ELCC

Highlights:

• Novel results in the treatment of EGFR-mutant non-small cell lung cancer
• Insights into the opportunities related to the use of immunotherapy, and the challenges related to IO resistance mechanisms that may occur in the treatment of patients with lung cancer
• Prevention, screening and early diagnosis of thoracic tumours: from new technologies aimed at improving screening to prevention measures beyond smoking
• Emerging evidence on the efficacy and the management of toxicities of antibody-drug conjugates